查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1857903

草銨膦市場按應用、作物、製劑和最終用途分類－2025-2032年全球預測

Glufosinate Market by Application, Crop, Formulation, End Use - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，草銨膦市場規模將達到 42.9 億美元，複合年成長率為 10.20%。

關鍵市場統計數據
基準年 2024 19.7億美元
預計年份：2025年 21.7億美元
預測年份 2032 42.9億美元
複合年成長率 (%) 10.20%

全面介紹草銨膦領域的最新進展，概述其農藝作用和監管壓力、供應鏈動態和商業性相關性。

草銨膦在現代農藝中佔據著舉足輕重的地位，它既是綜合雜草控制方案中非Glyphosate的替代品，也是抗性管理策略的補充。草銨膦的作用機制、藥理特性和製劑靈活性使其在各種種植系統中保持相關性，而不斷變化的監管審查和種植者偏好也在持續改變該產品的使用方式。在過去的幾個種植季中，相關人員推動了製劑、施用時間和管理方法的創新，力求在藥效與環境和監管因素之間取得平衡。

除了農藝性能外，產品的商業性生命週期還受到上游原料採購、組合藥物供應和下游監管批准的影響。需求模式反映了合規性促進因素和實際田間表現，因為種植者核准更具韌性的雜草控制方案，尤其關注雜草壓力大且有抗藥性風險的作物。因此，製造商、配方商和經銷商都在強調將化學、耕作和機械手段結合的綜合方法。

展望未來，引言部分概述了影響產品開發、市場進入和農場應用等決策的交叉因素。透過監管動態、營運限制和終端用戶期望來建立競爭格局，本部分為深入分析市場區隔、區域動態以及相關人員為保持競爭力並適應市場變化而需要採取的策略性應對措施奠定了基礎。

農藝、技術和商業性法規的變革力量正在塑造草銨膦策略和供應鏈定位的創新。

由於監管環境的調整、抗藥性管理的需求以及對永續性的日益重視，草銨膦的應用格局正在轉變。多個司法管轄區更嚴格的環境和毒理學審查流程迫使企業重新評估其註冊策略，並投資於更完善的安全性和管理專案。同時，抗除草劑雜草的蔓延提升了替代作用機制的價值，使草銨膦成為輪作計畫和綜合雜草管理通訊協定中的關鍵組成部分。

技術和商業性變革也顯而易見。配方科學的進步，提高了耐雨性、作物選擇性和桶混相容性，拓寬了施藥人員的工作窗口。數位化農藝工具實現了精準施藥，在最大限度提高藥效的同時減少了活性成分的使用；而主導的決策支援則幫助顧問制定能夠延緩抗藥性產生的組合方案。在供應方面，配方商和經銷商之間日益緊密的整合正在重塑產品的獲取和定價動態，而夥伴關係和契約製造在其中扮演著越來越重要的角色。

此外，主要買家和零售商的永續性承諾正促使供應鏈減少環境足跡並展現良好的管理能力。法律規範、農業要求和商業性永續性需求的共同作用，正在推動產品組合的合理化和創新，這不僅給現有參與企業也帶來了挑戰，同時也帶來了機會。

評估2025年關稅對草銨膦採購、生產和打入市場策略的供應鏈中斷和商業成本影響

美國2025年實施的關稅和貿易措施，導致草銨膦價值鏈中各參與者的成本結構和採購決策發生重大變化。某些前驅物化學品和製劑原料關稅的提高，增加了部分依賴進口的生產商的到岸成本，促使他們迅速重新評估供應商關係和物流模式。這些貿易政策的變化凸顯了供應鏈透明度、多元化採購策略和本地生產方案對於保護利潤率和維持供應連續性的重要性。

因此，製造商和配方師不得不權衡將更高的成本轉嫁給下游客戶與承受利潤率壓縮之間的利弊。在許多情況下，商務團隊實施了有針對性的價格調整，並加強了價值訊息，以證明價格調整的合理性；與此同時，採購部門加快了對低關稅地區替代供應商的資格審核。關稅環境也強化了遠期合約和庫存避險的獎勵，企業需要在營運成本方面做出權衡，同時也要避免在尖峰時段出現專案中斷。

值得注意的是，關稅環境對不同產業和地區的影響存在差異，那些已整合國內生產或擁有免稅供應鏈的公司從中受益。這也活性化了關於近岸外包（即將製劑生產能力轉移到更靠近主要需求中心的地方）的討論。總而言之，這些發展凸顯了在成本格局重新平衡的環境下，企業需要積極監控貿易政策並採取靈活的商業性應對措施，才能保持競爭力。

進階細分分析揭示了作物、配方和最終用途管道如何相互交織，從而影響產品策略和商業化。

基於細分市場的洞察揭示了不同的需求促進因素和營運重點，這些因素會影響產品策略和市場推廣方式。按應用場景分類，葉面噴布因其時間靈活且可與生長季內干預措施兼容，可分為出苗後和出苗前兩種情況，其中田間決策佔據主導地位；而種子處理和土壤施用則在需要有針對性的殘留控制或幼苗保護時發揮著特殊作用。這些細微差別會影響配方選擇、施藥設備規格以及面向諮詢管道的訊息。

基於作物的細分研究表明，玉米、大豆和小麥等作物因其生長週期、雜草頻譜和抗性特徵而呈現出不同的應用模式。玉米防治方案通常著重於速效除草劑或生長季內滾動施用除草劑，將草銨膦與其他除草劑結合使用，以應對多種雜草；而大豆防治方案則可能優先考慮收穫前或抽穗後針對性地進行除草劑耐受性狀的干涉。小麥則需要關注抽穗前殘效控制和選擇性混配，以確保生長季初期獲得潛在產量。

製劑的選擇——乾粉劑、液體劑或水分散顆粒劑——反映了操作便利性、溶解性、應用穩定性以及與農機設備的兼容性之間的權衡。乾粉劑可以減輕運輸重量和風險，液體劑易於混合且吸收迅速，而水分散顆粒劑則可實現精確計量，並在某些情況下提高儲存穩定性。最終用途細分為商業農業、工業和住宅用途，進一步影響了產品特性和法規要求。商業農業追求規模化和成本效益，工業應用需要獨特的標籤檢視和安全控制，而住宅應用則強調低劑量、易於使用的劑型。

這些細分層級相互交織，共同界定了顧客價值提案、分銷策略和研發重點。了解施用方式、作物類型、配方選擇和最終用途環境之間的相互作用，對於設計既能滿足田間實際需求又能符合監管和通路限制的產品和商業性策略至關重要。

對美洲、歐洲、中東和非洲以及亞太地區的需求促進因素、法規環境和供應鏈結構進行跨區域分析

美洲、歐洲、中東和非洲以及亞太地區的區域促進因素正在以截然不同的方式塑造需求模式、法規環境和供應鏈結構。在美洲，多樣化的種植系統和大規模商業性農業催生了對操作靈活性更高的除草劑的強勁需求，而一些地區仍然受到鼓勵使用成熟化學物質並嚴格管理的法律規範的約束。南北貿易流動和物流基礎設施也會影響配方創新產品到達種植者手中的速度，進而影響活性成分的籌資策略。

歐洲、中東和非洲的監管審查力度很大，而且往往因地區而異。有些市場會進行嚴格的環境評估，而有些市場則優先考慮基本農業投入品的供應。這種不均衡的監管環境迫使企業尋求有針對性的註冊和特定地區的安全資料包，從而凸顯了證明其符合區域永續性預期的重要性。在這些地區，市場進入往往取決於一份完善的資料包和一套經證實有效的管理方案。

在亞太地區，集約化種植系統和快速接受新技術的種植者群體，既需要高效的解決方案，也需要針對當地實際情況量身定做的配方。區域製造地和附近的原料供應商具有成本優勢，但監管差異和複雜的進口制度需要謹慎對待。在任何地區，本地分銷網路、推廣服務和通路合作夥伴都會對產品的普及率產生顯著影響，因此，制定在地化的商業化策略對於成功至關重要。

競爭格局分析表明，配方能力、監管靈活性、生產規模和分銷能力是核心差異化因素。

草銨膦價值鏈中的競爭力量取決於製劑能力、監管能力、生產規模和分銷網路。擁有強大研發能力和一體化生產能力的公司往往能夠維持價格彈性，並能快速應對規格變更或突如其來的需求高峰。相反，依賴契約製造或供應鏈分散的公司更容易受到投入成本波動和貿易政策變化的影響，這些因素會擠壓利潤空間並延遲產品上市。

該領域的策略舉措包括：最佳化產品組合，專注於高性能配方；有針對性地收購配方技術和區域註冊資訊；以及共同開發契約加速市場准入並分擔監管風險。對應用技術和監管專案的投入也是主要企業脫穎而出的關鍵因素。強大的分銷能力仍然是一項重要的競爭優勢，而將農藝諮詢服務與售後服務支援共用的網路已被證明在推動商業種植者採用相關產品方面尤為有效。

此外，投資於數位農藝和決策支援工具的公司，透過將產品推薦整合到更廣泛的作物管理平台中，正在建立更牢固的客戶關係。將產品性能與可驗證的環境和職業安全實踐相結合的公司，能夠滿足監管機構和買方主導的永續性要求，從而保障市場進入和高階市場定位。

為製造商、經銷商和顧問提供切實可行的建議，以增強配方適應性、監管應對力、供應鏈靈活性和整合商業策略。

產業領導者可以採取一系列切實可行的措施來保護利潤率、加速推廣應用並降低草銨膦市場的監管和供應鏈風險。優先考慮製劑多樣化，以滿足不同的應用領域和使用者偏好，投資開發符合當地設施標準和儲存規範的液體、乾粉和顆粒劑型。同時，擴大管理和田間試驗項目，以證明其在各種農業操作條件下的功效，並支持重點地區的註冊申請。

透過對關鍵投入品的多個供應商進行資格認證、協商靈活的採購協議以及考慮區域混合和聯合包裝，增強供應鏈韌性，從而減輕關稅的影響。利用預測性採購和庫存管理，平衡高峰期缺貨的營運風險和成本。盡可能加快核准流程，並透過積極投資安全和環境資料集、參與產業工作小組以影響政策時間表以及與監管機構保持透明溝通，加強與監管機構的互動。

最後，我們正透過與數位化農藝供應商合作、提供決策支援工具以及建立綜合雜草管理諮詢管道，將我們的產品融入更廣泛的作物管理解決方案中。這種整合式方法提高了產品的相關性，減少了對單一技術解決方案的依賴，並促進了長期管理，同時使我們的銷售團隊能夠闡明引人注目的價值提案，從而證明其高階定位的合理性。

一種透明的、多方法的研究途徑，結合了初步的監管訪談和供應鏈分析、同行檢驗和有據可查的假設。

本執行摘要的研究基礎結合了來自行業相關人員的初步研究、嚴謹的二次檢驗以及反覆的專家評審，以確保提供平衡且切實可行的見解。主要研究內容包括對農藝師、配方研發人員、供應鏈經理和監管專家的結構化訪談，從而獲得對田間優先事項和商業性限制因素的第一手觀察。此外，還對分銷網路進行了調查，以了解不同終端用戶管道和種植系統中產品的推廣應用促進因素。

二手研究查閱了監管文件、專家農藝研究、配方專利和貿易政策出版物，並將其與一手研究聯繫起來，以識別跨區域模式。透過供應鏈映射，追蹤關鍵物質的流動，識別前驅供應中的濃度風險，並評估關稅方案的潛在影響。所有數據均與多個資訊來源進行交叉核對，並由專家小組審核。

為了提高研究的可重複性和透明度，我們詳細記錄了市場區隔、地理分析和影響分析方法，以及決策規則、納入標準和假設。我們進行了敏感度分析，以了解監管時間表、關稅水平和雜草抗藥性流行程度的變化如何影響戰略重點，從而為相關人員提供了一個框架，以便他們根據自身的風險接受度和營運限制調整我們的建議。

策略結論強調了製劑創新、監管參與和供應鏈靈活性對於確保草銨膦長期市場地位的重要性。

總而言之，草銨膦仍然是現代雜草管理的重要工具，但其未來發展軌跡將取決於相關人員如何應對監管壓力、供應鏈變化以及不斷變化的種植者期望。投資配方創新、加強監管體係以及提高供應鏈靈活性以抵禦關稅引起的成本波動是關鍵挑戰。那些積極主動地將產品開發與當地農藝需求和監管實際情況相結合的公司，將更有利於進入市場並保持商業性競爭力。

未來前景將有利於那些能夠將卓越技術、靈活營運和清晰的客戶價值溝通相結合的公司。透過將草銨膦產品整合到更廣泛的作物管理解決方案中，並展現可衡量的安全性和環境績效，即使在複雜的市場環境中，這些公司也能保護淨利率並抓住成長機會。最終，策略重點、基於證據的監管溝通以及嚴謹的執行力將決定哪些公司能夠成功地將當前的挑戰轉化為長期優勢。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在抗Glyphosate雜草管理專案中，擴大採用草銨膦類除草劑混合物
  • 北美和歐盟農業市場對草銨膦使用的監管核准和限制
  • 開發高濃度配方，以提高療效並減少用量。
  • 透過將草銨膦與精密農業技術結合，實現有針對性的雜草控制
  • 專利到期對草銨膦定價和非專利除草劑生產商准入的影響
  • 新興國家對草銨膦的需求不斷成長，這主要得益於永續農業計劃的推動。
  • 供應鏈挑戰和活性成分採購影響草銨膦的供應和成本趨勢。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8.草銨膦市場應用

  • 葉面噴布
    • 出苗後
    • 出苗前
  • 種子處理
  • 土壤

9. 按作物分類的草銨膦市場

  • 玉米
  • 大豆
  • 小麥

第10章 按劑型分類的草銨膦市場

  • 乾粉狀可流動
  • 液體
  • 水分散性顆粒

11.草銨膦市場（依最終用途）

  • 商業農業
  • 工業的
  • 住宅

第12章 各地區草銨膦市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章：按群體分類的草銨膦市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國草銨膦市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • BASF SE
    • Bayer AG
    • UPL Limited
    • ADAMA Ltd
    • Nufarm Limited
    • Sipcam Oxon SpA
    • Sumitomo Chemical Co., Ltd
    • Zhejiang Xinan Chemical Industrial Group Co., Ltd
    • Gowan Company LLC
    • Qingdao Seawin Biotech Group
Product Code: MRR-C002B1C994EB

The Glufosinate Market is projected to grow by USD 4.29 billion at a CAGR of 10.20% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.97 billion
Estimated Year [2025] USD 2.17 billion
Forecast Year [2032] USD 4.29 billion
CAGR (%) 10.20%

Comprehensive introduction to the evolving glufosinate landscape outlining agronomic roles regulatory pressures supply chain dynamics and commercial relevance

Glufosinate occupies a distinct position within modern agronomy, serving as a non-glyphosate option in integrated weed control programs and as a complement to resistance management strategies. Its herbicidal mode of action, regulatory profile, and formulation flexibility have maintained relevance across diverse cropping systems, while shifting regulatory scrutiny and evolving grower preferences continually reshape how the product is deployed. Over recent seasons, stakeholders have balanced efficacy against environmental and regulatory considerations, prompting innovation in formulation, application timing, and stewardship practices.

Beyond agronomic performance, the product's commercial lifecycle is influenced by upstream raw material sourcing, formulant availability, and downstream regulatory approvals. As growers seek resilient weed control programs, demand patterns reflect both compliance drivers and practical field performance, with particular emphasis on crops where weed pressure and resistance risks are high. Consequently, manufacturers, formulators, and distributors are placing greater emphasis on integrated approaches that couple chemical tools with cultural and mechanical measures.

Looking ahead, the introduction outlines the cross-cutting forces shaping decisions across product development, market access, and on-farm adoption. By framing the landscape through regulatory dynamics, operational constraints, and end-user expectations, this section sets the context for deeper analysis of segmentation, regional dynamics, and strategic responses necessary for stakeholders to remain competitive and compliant.

Transformative regulatory agronomic technological and commercial forces reshaping glufosinate strategy innovation and supply chain positioning

The glufosinate landscape is undergoing transformative shifts driven by regulatory recalibration, resistance management needs, and a rising emphasis on sustainability. Stricter environmental and toxicological review processes across multiple jurisdictions have forced firms to reassess registration strategies and invest in enhanced safety and stewardship programs. Simultaneously, the proliferation of herbicide-resistant weed populations has elevated the value proposition of alternative modes of action, making glufosinate a strategic component of rotation programs and integrated weed management protocols.

Technological and commercial shifts are also apparent. Formulation science is advancing to improve rainfastness, crop selectivity, and tank-mix compatibility, thereby expanding operational windows for applicators. Digital agronomy tools are enabling precision application that reduces active ingredient use while maximizing efficacy, and analytics-driven decision support is helping advisors prescribe combinations that delay resistance onset. On the supply side, consolidation among formulators and distributors continues to reshape access and pricing dynamics, with partnerships and contract manufacturing playing an increasingly important role.

Moreover, sustainability commitments from major buyers and retailers are pressuring supply chains to demonstrate lower environmental footprints and robust stewardship. This confluence of regulatory oversight, agronomic necessity, and commercial sustainability requirements is driving portfolio rationalization and innovation, creating both challenges and opportunities for incumbents and new entrants alike.

Assessment of the 2025 tariff-driven supply chain disruptions and commercial cost implications for glufosinate sourcing manufacturing and market access strategies

The imposition of tariffs and trade measures in the United States in 2025 has materially altered cost structures and sourcing decisions for players within the glufosinate value chain. Increased duties on certain precursor chemicals and formulation inputs have elevated landed costs for some import-dependent manufacturers, prompting rapid reassessment of supplier relationships and logistics models. These trade policy shifts have emphasized the importance of supply-chain visibility, multi-sourcing strategies, and localized manufacturing options to preserve margin and maintain supply continuity.

As a consequence, manufacturers and formulators have had to weigh the trade-offs between passing higher costs to downstream customers and absorbing margin compressions. In many cases, commercial teams implemented targeted price adjustments alongside enhanced value messaging to justify changes, while procurement functions accelerated qualification of alternative suppliers from lower-tariff jurisdictions. The tariff environment also strengthened incentives for forward contracting and inventory hedging, with companies balancing working capital impacts against the need to avoid program disruptions during peak application seasons.

Importantly, the tariff landscape created a differential impact across segments and regions, benefiting firms with integrated domestic production or those with secure access to tariff-exempt supply chains. It also stimulated conversations about nearshoring and co-locating formulation capacity closer to key demand centers. Collectively, these developments have underscored the necessity of proactive trade-policy monitoring and agile commercial responses to preserve competitiveness in a recalibrated cost environment.

Nuanced segmentation analysis revealing how application modes crops formulations and end-use channels intersect to shape product strategy and commercialization

Segmentation-driven insights reveal differentiated demand drivers and operational priorities that influence product strategy and go-to-market approaches. When examined by application, foliar use-divided into post-emergence and pre-emergence scenarios-dominates field-level decision-making due to flexibility in timing and compatibility with in-season interventions, while seed treatment and soil applications serve niche roles where targeted residual control or seedling protection is required. These subtleties impact formulation choices, application equipment specifications, and stewardship messaging for advisory channels.

Crop-based segmentation shows that crops such as corn, soybean, and wheat present distinct use-case patterns rooted in cropping cycles, weed spectra, and tolerance profiles. Corn programs frequently emphasize knockdown and in-season rolling programs that integrate glufosinate with other herbicides to manage diverse weed mixes, whereas soybean programs may prioritize pre-harvest or targeted post-emergence interventions that align with herbicide-tolerance traits. Wheat systems often require attention to pre-emergence residual control and selective tank mixes to protect yield potential during early growth stages.

Formulation preferences-spanning dry flowable, liquid, and water dispersible granules-reflect trade-offs between handling convenience, solubility, spray stability, and on-farm equipment compatibility. Dry flowables can reduce shipping weight and risk, liquids offer ease of mixing and rapid uptake, and water dispersible granules provide precise dosing and improved storage stability for certain channels. End-use segmentation into commercial agriculture, industrial, and residential applications further modulates product characteristics and regulatory demands, with commercial agriculture driving scale and cost-efficiency, industrial uses requiring tailored labeling and safety controls, and residential applications focusing on low-dose, user-friendly formats.

Together, these segmentation layers intersect to define customer value propositions, distribution strategies, and R&D priorities. Understanding how application mode, crop type, formulation choice, and end-use context interact is essential for designing products and commercial approaches that meet field-level expectations while satisfying regulatory and channel constraints.

Cross-regional analysis of demand drivers regulatory environments and supply chain structures across the Americas Europe Middle East & Africa and Asia-Pacific

Regional dynamics shape demand patterns, regulatory exposure, and supply chain architectures in materially different ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, diverse cropping systems and large-scale commercial agriculture create robust demand for operationally flexible herbicides, while regulatory frameworks in some jurisdictions remain conducive to the use of established chemistries under strict stewardship. North-South trade flows and logistical infrastructure also determine how quickly formulation innovations reach growers and influence procurement strategies for active ingredients.

Within Europe, Middle East & Africa, regulatory scrutiny is often intense and variable by sub-region, with some markets enforcing stringent environmental assessments and others prioritizing access for essential agricultural inputs. This uneven regulatory landscape compels firms to pursue targeted registrations and localized safety data packages, and it elevates the importance of demonstrating compliance with regional sustainability expectations. Market access in these geographies frequently hinges on robust data packages and demonstrated stewardship programs.

In the Asia-Pacific region, high-intensity cropping systems and fast-adopting grower communities create demand for both high-efficacy solutions and specialized formulations that accommodate local practices. Regional manufacturing hubs and proximate raw material suppliers can offer cost advantages, but regulatory variability and complex import regimes require careful navigation. Across all regions, local distribution networks, extension services, and channel partners significantly influence adoption velocity, making regionally tailored commercialization strategies essential for success.

Competitive landscape analysis emphasizing formulation capability regulatory agility manufacturing scale and distribution strength as core differentiators

Competitive dynamics in the glufosinate value chain are shaped by capabilities in formulation, regulatory affairs, production scale, and channel reach. Firms that combine robust R&D with integrated manufacturing capacity tend to retain pricing flexibility and can respond more rapidly to specification changes or sudden demand spikes. Conversely, companies that rely on contract manufacturing or fragmented supply chains are more exposed to input cost volatility and trade-policy shifts, which can compress margins or delay product launches.

Strategic behaviors observed in the sector include portfolio rationalization to focus on high-performing formulations, targeted acquisitions to acquire formulation technology or regional registrations, and co-development agreements that accelerate market entry while sharing regulatory risk. Investment in application technology and stewardship programs also differentiates leading companies, as buyers increasingly demand verifiable safety and efficacy data. Distribution strength remains a critical competitive advantage, with networks that combine agronomic advisory services and after-sales support proving particularly effective at driving adoption among commercial growers.

Additionally, companies investing in digital agronomy and decision-support tools are creating stickier customer relationships by embedding product recommendations within broader crop management platforms. Those that couple product performance with demonstrable environmental and occupational safety measures are better positioned to meet the convergence of regulatory and buyer-driven sustainability requirements, thereby protecting market access and premium positioning.

Actionable recommendations for manufacturers distributors and advisors to enhance formulation resilience regulatory readiness supply-chain agility and integrated commercial strategies

Industry leaders can adopt a series of practical measures to protect margins, accelerate adoption, and reduce regulatory and supply-chain risk in the glufosinate market. Prioritize formulation diversification to address varied application windows and handler preferences, investing in liquid, dry flowable, and granule formats that align with local equipment norms and storage realities. At the same time, expand stewardship and field-trial programs that document efficacy under diverse agronomic conditions and support registration dossiers across priority jurisdictions.

Strengthen supply-chain resilience by qualifying multiple suppliers for critical inputs, negotiating flexible sourcing agreements, and considering localized blending or co-packing to mitigate tariff exposure. Use predictive procurement and inventory management to balance cost against the operational risk of stockouts during peak seasons. Enhance regulatory engagement by proactively investing in safety and environmental datasets, participating in industry working groups to influence policy timelines, and maintaining transparent communication with regulators to expedite approvals when possible.

Finally, embed product offerings within broader crop management solutions by partnering with digital agronomy providers, offering decision-support tools, and training advisory channels on integrated weed management. These integrated approaches increase product relevance, reduce reliance on single-technology solutions, and enable commercial teams to articulate a compelling value proposition that justifies premium positioning while promoting long-term stewardship.

Transparent multi-method research approach integrating primary interviews regulatory and supply-chain analysis with expert validation and documented assumptions

The research underpinning this executive summary combined primary engagement with industry stakeholders, rigorous secondary-source validation, and iterative expert review to ensure balanced and actionable findings. Primary inputs included structured interviews with agronomists, formulators, supply-chain managers, and regulatory specialists, enabling direct observation of field-level priorities and commercial constraints. These interviews were complemented by targeted surveys of distribution networks to capture adoption drivers across different end-use channels and cropping systems.

Secondary research encompassed regulatory filings, peer-reviewed agronomic studies, formulation patents, and trade policy publications to contextualize primary observations and identify cross-jurisdictional patterns. Supply-chain mapping exercises traced key material flows, identified concentration risks in precursor supply, and evaluated potential impacts from tariff scenarios. All data points were cross-checked against multiple sources and reviewed by an expert panel to reconcile divergent perspectives and ensure analytic rigor.

To enhance reproducibility and transparency, methodologies for segmentation, regional analysis, and impact assessment were documented with decision rules, inclusion criteria, and assumptions. Sensitivity analyses were performed to understand how variations in regulatory timelines, tariff levels, and weed-resistance prevalence could influence strategic priorities, thereby providing stakeholders with a framework to adapt recommendations to their specific risk tolerance and operational constraints.

Strategic conclusion emphasizing the importance of formulation innovation regulatory engagement and supply-chain agility to secure long-term glufosinate relevance

In conclusion, glufosinate remains an important tool within modern weed management arsenals, but its future trajectory is contingent on how well stakeholders navigate regulatory pressures, supply-chain shifts, and evolving grower expectations. Key imperatives include investing in formulation innovation, strengthening stewardship frameworks, and enhancing supply-chain flexibility to withstand tariff-driven cost volatility. Firms that proactively align product development with region-specific agronomic needs and regulatory realities will be better positioned to sustain market access and commercial relevance.

The road ahead favors those who can couple technical excellence with operational agility and clear value communication to customers. By integrating glufosinate offerings into broader crop management solutions and by demonstrating measurable safety and environmental performance, companies can preserve margins and unlock growth opportunities even as the market environment becomes more complex. Ultimately, strategic focus, evidence-based regulatory engagement, and disciplined execution will determine which organizations successfully convert current challenges into long-term advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of glufosinate-based herbicide mixtures in glyphosate resistant weed management programs
  • 5.2. Regulatory approvals and restrictions for glufosinate use across North American and EU agricultural markets
  • 5.3. Development of high-concentration glufosinate formulations to improve efficacy and reduce application rates
  • 5.4. Integration of glufosinate with precision agriculture technologies for targeted weed control
  • 5.5. Impact of patent expirations on glufosinate pricing and entry of generic herbicide manufacturers
  • 5.6. Expansion of glufosinate demand in emerging economies driven by sustainable agriculture initiatives
  • 5.7. Supply chain challenges and active ingredient sourcing affecting glufosinate availability and cost dynamics

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Glufosinate Market, by Application

  • 8.1. Foliar
    • 8.1.1. Post Emergence
    • 8.1.2. Pre Emergence
  • 8.2. Seed Treatment
  • 8.3. Soil

9. Glufosinate Market, by Crop

  • 9.1. Corn
  • 9.2. Soybean
  • 9.3. Wheat

10. Glufosinate Market, by Formulation

  • 10.1. Dry Flowable
  • 10.2. Liquid
  • 10.3. Water Dispersible Granules

11. Glufosinate Market, by End Use

  • 11.1. Commercial Agriculture
  • 11.2. Industrial
  • 11.3. Residential

12. Glufosinate Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Glufosinate Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Glufosinate Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. BASF SE
    • 15.3.2. Bayer AG
    • 15.3.3. UPL Limited
    • 15.3.4. ADAMA Ltd
    • 15.3.5. Nufarm Limited
    • 15.3.6. Sipcam Oxon S.p.A
    • 15.3.7. Sumitomo Chemical Co., Ltd
    • 15.3.8. Zhejiang Xinan Chemical Industrial Group Co., Ltd
    • 15.3.9. Gowan Company LLC
    • 15.3.10. Qingdao Seawin Biotech Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLUFOSINATE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GLUFOSINATE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS GLUFOSINATE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL GLUFOSINATE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GLUFOSINATE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. GLUFOSINATE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GLUFOSINATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GLUFOSINATE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GLUFOSINATE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GLUFOSINATE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GLUFOSINATE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS GLUFOSINATE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS GLUFOSINATE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 130. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 166. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 173. AFRICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. AFRICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 178. AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GLUFOSINATE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GLUFOSINATE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. ASEAN GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. ASEAN GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. ASEAN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. ASEAN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. ASEAN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 204. ASEAN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 211. GCC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GCC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GCC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. GCC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. GCC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 216. GCC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 217. GCC GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 218. GCC GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 219. GCC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 220. GCC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 221. GCC GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 222. GCC GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 235. BRICS GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. BRICS GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. BRICS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. BRICS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. BRICS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 240. BRICS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 247. G7 GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. G7 GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. G7 GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. G7 GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. G7 GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 252. G7 GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 253. G7 GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 254. G7 GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 255. G7 GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 256. G7 GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 257. G7 GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 258. G7 GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 259. NATO GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. NATO GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. NATO GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. NATO GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. NATO GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 264. NATO GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 265. NATO GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 266. NATO GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 267. NATO GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 268. NATO GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 269. NATO GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 270. NATO GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL GLUFOSINATE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. UNITED STATES GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED STATES GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED STATES GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED STATES GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 277. UNITED STATES GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED STATES GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 283. CANADA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. CANADA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. CANADA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 286. CANADA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 287. CANADA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 288. CANADA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 293. MEXICO GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. MEXICO GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. MEXICO GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 296. MEXICO GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 297. MEXICO GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 298. MEXICO GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 299. MEXICO GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 300. MEXICO GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 301. MEXICO GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 302. MEXICO GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 303. BRAZIL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. BRAZIL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. BRAZIL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 306. BRAZIL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 307. BRAZIL GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 308. BRAZIL GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 309. BRAZIL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 310. BRAZIL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 311. BRAZIL GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 312. BRAZIL GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 316. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 318. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 323. GERMANY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. GERMANY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. GERMANY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 326. GERMANY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 327. GERMANY GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 328. GERMANY GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 329. GERMANY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 330. GERMANY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 331. GERMANY GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 332. GERMANY GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 333. FRANCE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. FRANCE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 335. FRANCE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 336. FRANCE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 337. FRANCE GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 338. FRANCE GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 339. FRANCE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 340. FRANCE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 341. FRANCE GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 342. FRANCE GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 343. RUSSIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 344. RUSSIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 345. RUSSIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 346. RUSSIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 347. RUSSIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 348. RUSSIA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 349. RUSSIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 350. RUSSIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 351. RUSSIA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 352. RUSSIA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 353. ITALY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 354. ITALY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 355. ITALY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 356. ITALY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 357. ITALY GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 358. ITALY GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 359. ITALY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 360. ITALY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 361. ITALY GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 362. ITALY GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 363. SPAIN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 364. SPAIN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 365. SPAIN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 366. SPAIN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 367. SPAIN GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 368. SPAIN GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 369. SPAIN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 370. SPAIN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 371. SPAIN GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 372. SPAIN GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 373. CHINA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 374. CHINA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 375. CHINA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 376. CHINA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 377. CHINA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 378. CHINA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 379. CHINA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 380. CHINA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 381. CHINA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 382. CHINA GLUFOSINATE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 383. INDIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 384. INDIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 385. INDIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2024 (USD MILLION)
  • TABLE 386. INDIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2025-2032 (USD MILLION)
  • TABLE 387. INDIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
  • TABLE 388. INDIA GLUFOSINATE MARKET SIZE, BY CROP, 2025-2032 (USD MILLION)
  • TABLE 389. INDIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 390. INDIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2025-2